Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia

Yuan Hung Yeh, Junn Liang Chang, Pei Ching Hsiao, Shih Ming Tsao, Chien Huang Lin, Shang Jyh Kao, Ming Chih Chou, Shun Fa Yang, Ming Hsien Chien

研究成果: 雜誌貢獻文章同行評審

8 引文 斯高帕斯(Scopus)


Background: The aim of this study was to investigate the differential plasma levels of lipocalin 2 (LCN2) and its complex with MMP-9 (where MMP is matrix metalloproteinase) before and after antibiotic treatment in hospitalized adult patients with community-acquired pneumonia (CAP). Method: Plasma LCN2 and LCN2/MMP-9 complex levels were measured in 61 adult patients with CAP and 60 healthy controls using commercial enzyme-linked immunosorbent assay (ELISA). Results: A decrease in the number of white blood cells (WBCs) and neutrophils and decreases in the levels of C-reactive protein (CRP), LCN2, and LCN2/MMP-9 complex were observed after antibiotic treatment. The plasma level of LCN2, but not that of CRP, was correlated with the severity of CAP based on the Pneumonia Severity Index (PSI; r = 0.333, P = 0.009), confusion, urea, respiratory rate and blood pressure (CURB)-65 (r = 0.288, P = 0.024), and Acute Physiology And Chronic Health Evaluation II (APACHE II) scores (r = 0.328, P = 0.010). LCN2 levels were also significantly correlated with LCN2/MMP-9 levels and the numbers of WBCs or neutrophils. Conclusions: Plasma levels of LCN2 and the LCN2/MMP-9 complex can act as adjuvant diagnostic biomarkers for CAP. Plasma LCN2 might play a further role in the clinical assessment of the severity of CAP, which could potentially guide the development of future treatment strategies.
頁(從 - 到)253-260
期刊Journal of Clinical Laboratory Analysis
出版狀態已發佈 - 7月 2013

ASJC Scopus subject areas

  • 免疫學和過敏
  • 血液學
  • 公共衛生、環境和職業健康
  • 臨床生物化學
  • 醫學實驗室技術
  • 生物化學(醫學)
  • 微生物學(醫學)


深入研究「Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia」主題。共同形成了獨特的指紋。